India’s Gland Pharma scores record listing
Gland Pharma has completed India’s largest pharmaceutical IPO, a Rp65bn ($870.6m) deal that sailed through on demand from institutional accounts. But the issuer’s Chinese ties and a wobble in pharma stocks blunted retail investor interest. Jonathan Breen reports.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: